Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
The findings mentioned above have led CBT for BED (Dalle Grave et al., 2024) to adopt a clinical stance on using GLP-1RAs for patients with BED who also have higher body weight
Sources conflict as to the timing, with some indicating that the Green Frog feeds mainly at night, while others stating that this species feeds as frequently during the day as at night
Mantripragada KK, Spurlock G, Kluwe L, Chuzhanova N, Ferner RE, Frayling IM, et al
Findings that GLP-1 medicines such as semaglutide are renoprotective in people with T2D and obesity (6, 7) provide new options for improving renal outcomes and decreasing the likelihood of developing end stage kidney disease
Finally, the application of new genetic transformation techniques and plant breeding strategies is discussed